Cargando…

Multi-omics characterization and therapeutic liability of ferroptosis in melanoma

Detalles Bibliográficos
Autores principales: He, Yi, Dong, Yu, Chen, Yong, Zhang, Guanxiong, Zhang, Hailun, Lei, Guang, Du, Yanhua, Chen, Xiang, Ye, Youqiong, Liu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363465/
https://www.ncbi.nlm.nih.gov/pubmed/35945204
http://dx.doi.org/10.1038/s41392-022-01067-y
_version_ 1784764934418071552
author He, Yi
Dong, Yu
Chen, Yong
Zhang, Guanxiong
Zhang, Hailun
Lei, Guang
Du, Yanhua
Chen, Xiang
Ye, Youqiong
Liu, Hong
author_facet He, Yi
Dong, Yu
Chen, Yong
Zhang, Guanxiong
Zhang, Hailun
Lei, Guang
Du, Yanhua
Chen, Xiang
Ye, Youqiong
Liu, Hong
author_sort He, Yi
collection PubMed
description
format Online
Article
Text
id pubmed-9363465
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-93634652022-08-11 Multi-omics characterization and therapeutic liability of ferroptosis in melanoma He, Yi Dong, Yu Chen, Yong Zhang, Guanxiong Zhang, Hailun Lei, Guang Du, Yanhua Chen, Xiang Ye, Youqiong Liu, Hong Signal Transduct Target Ther Letter Nature Publishing Group UK 2022-08-10 /pmc/articles/PMC9363465/ /pubmed/35945204 http://dx.doi.org/10.1038/s41392-022-01067-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
He, Yi
Dong, Yu
Chen, Yong
Zhang, Guanxiong
Zhang, Hailun
Lei, Guang
Du, Yanhua
Chen, Xiang
Ye, Youqiong
Liu, Hong
Multi-omics characterization and therapeutic liability of ferroptosis in melanoma
title Multi-omics characterization and therapeutic liability of ferroptosis in melanoma
title_full Multi-omics characterization and therapeutic liability of ferroptosis in melanoma
title_fullStr Multi-omics characterization and therapeutic liability of ferroptosis in melanoma
title_full_unstemmed Multi-omics characterization and therapeutic liability of ferroptosis in melanoma
title_short Multi-omics characterization and therapeutic liability of ferroptosis in melanoma
title_sort multi-omics characterization and therapeutic liability of ferroptosis in melanoma
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363465/
https://www.ncbi.nlm.nih.gov/pubmed/35945204
http://dx.doi.org/10.1038/s41392-022-01067-y
work_keys_str_mv AT heyi multiomicscharacterizationandtherapeuticliabilityofferroptosisinmelanoma
AT dongyu multiomicscharacterizationandtherapeuticliabilityofferroptosisinmelanoma
AT chenyong multiomicscharacterizationandtherapeuticliabilityofferroptosisinmelanoma
AT zhangguanxiong multiomicscharacterizationandtherapeuticliabilityofferroptosisinmelanoma
AT zhanghailun multiomicscharacterizationandtherapeuticliabilityofferroptosisinmelanoma
AT leiguang multiomicscharacterizationandtherapeuticliabilityofferroptosisinmelanoma
AT duyanhua multiomicscharacterizationandtherapeuticliabilityofferroptosisinmelanoma
AT chenxiang multiomicscharacterizationandtherapeuticliabilityofferroptosisinmelanoma
AT yeyouqiong multiomicscharacterizationandtherapeuticliabilityofferroptosisinmelanoma
AT liuhong multiomicscharacterizationandtherapeuticliabilityofferroptosisinmelanoma